Recombinant Human TNFRSF13B

Product Specifications

Product Name Alternative

CD 267, CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, MGC39952, OTTHUMP00000065442, TNFRSF 13B, TNFRSF 14B, TNFRSF13B, TNFRSF13B protein, TNFRSF14B, TR13B_HUMAN, Transmembrane activator and CAML interactor, Tumor necrosis factor receptor 13B, Tumor necrosis factor receptor superfamily member 13B

UniProt

O14836

Expression Region

1-160

Host

E.Coli

Tag

N-terminal His Tag

Applications

Western Blot, ELISA

Field of Research

Immunology, Signal Transduction

Endotoxin

< 1 EU/µg as determined by LAL test.

Purity

Greater than 90% as determined by SDS-PAGE.

Form

Lyophilized powder

Reconstitution

Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

Molecular Weight

17.5 kDa

Shipping Conditions

4°C with ice bag

Storage Conditions

The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.